Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (201-210 of 359) with videos related to

Pageof 36
Sort By:
Alzheimer'S Research & Therapy|March 22, 2018
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degenerationJoery Goossens, Maria Bjerke, Sara Van Mossevelde, et al.
Human Molecular Genetics|October 25, 2007
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitroJulie van der Zee, Hazel Urwin, Sebastiaan Engelborghs, et al.
Neurobiology of Disease|June 12, 2021
Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosisJulie van der Zee, Lubina Dillen, Yalda Baradaran-Heravi, et al.
Human Mutation|May 1, 2009
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian populationKaren Nuytemans, Bram Meeus, David Crosiers, et al.
Journal of Alzheimer'S Disease : JAD|February 4, 2017
BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy ParticipantsMaarten Timmers, Soraia Barão, Bianca Van Broeck, et al.
The Lancet Regional Health. Europe|May 30, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointLinus Jönsson, Anders Wimo, Ron Handels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Validation of the Semiquantitative Static SUVR Method for <sup>18</sup>F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input FunctionJulie Ottoy, Jeroen Verhaeghe, Ellis Niemantsverdriet, et al.
Neurology. Genetics|September 27, 2016
Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTDJulie van der Zee, Peter Mariën, Roeland Crols, et al.
Neuroimage. Clinical|March 31, 2019
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and <sup>18</sup>F-FDG-PET imagingJulie Ottoy, Ellis Niemantsverdriet, Jeroen Verhaeghe, et al.
Neurobiology of Aging|September 22, 2021
Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementiaEline A J Willemse, Anne Sieben, Charisse Somers, et al.
Pageof 36

Showing results (201-210 of 359) with videos related to

Sort By:
Pageof 36
Alzheimer'S Research & Therapy|March 22, 2018
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degenerationJoery Goossens, Maria Bjerke, Sara Van Mossevelde, et al.
Human Molecular Genetics|October 25, 2007
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitroJulie van der Zee, Hazel Urwin, Sebastiaan Engelborghs, et al.
Neurobiology of Disease|June 12, 2021
Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosisJulie van der Zee, Lubina Dillen, Yalda Baradaran-Heravi, et al.
Human Mutation|May 1, 2009
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian populationKaren Nuytemans, Bram Meeus, David Crosiers, et al.
Journal of Alzheimer'S Disease : JAD|February 4, 2017
BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy ParticipantsMaarten Timmers, Soraia Barão, Bianca Van Broeck, et al.
The Lancet Regional Health. Europe|May 30, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointLinus Jönsson, Anders Wimo, Ron Handels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
Validation of the Semiquantitative Static SUVR Method for <sup>18</sup>F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input FunctionJulie Ottoy, Jeroen Verhaeghe, Ellis Niemantsverdriet, et al.
Neurology. Genetics|September 27, 2016
Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTDJulie van der Zee, Peter Mariën, Roeland Crols, et al.
Neuroimage. Clinical|March 31, 2019
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and <sup>18</sup>F-FDG-PET imagingJulie Ottoy, Ellis Niemantsverdriet, Jeroen Verhaeghe, et al.
Neurobiology of Aging|September 22, 2021
Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementiaEline A J Willemse, Anne Sieben, Charisse Somers, et al.
Pageof 36